Globus Medical Reports First Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical (GMED) PT Raised to $58 at Needham & Company
May 3, 2018 6:38 AM EDTNeedham & Company raised its price target on Globus Medical (NYSE: GMED) to $58.00 (from $57.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "GMED's 1Q18 revenue and EPS beat consensus and management raised its 2018 revenue and EPS guidance. The guidance increases were... More
Globus Medical (GMED) Tops Q1 EPS by 5c; Raises Outlook
May 2, 2018 4:26 PM EDTGlobus Medical (NYSE: GMED) reported Q1 EPS of $0.41, $0.05 better than the analyst estimate of $0.36. Revenue for the quarter came in at $174.4 million versus the consensus estimate of $167.89 million.
GUIDANCE:
Globus Medical sees FY2018 EPS of $1.52, versus prior of $1.50 and the... More
